CYBB and type 2 diabetes mellitus: Type 2 diabetes (T2D) represents a major global health challenge, characterized by insulin resistance, β-cell dysfunction and chronic inflammation closely linked to reactive oxygen species (ROS) production, particularly through NADPH oxidase 2 (NOX2).